We estimate that OEM is the lowest-margin segment for CTT, and should therefore impact EBIT to a lesser extent. However, if we assume FY’21 sales of SEK 150m (mid-point of guidance), this would implicitly lower our sales assumptions by 17% but EBIT by mid-to-high single-digits.
On the right track, but at a slower than expected pace
We are somewhat discouraged by the slower than expected OEM recovery. On the positive side, we believe demand from 2022 and onwards should be strong, although from a lower starting point. The stock is flat L1M vs. the Carnegie Smallcap index at +7% and is trading at (pre-Q2 ests) 21-17x EV/EBIT ‘22e-‘23e.